Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease with a largely unknown pathogenesis. The most common gene mutation in both familial and sporadic ALS is the C9orf72 repeat expansion. Investigating asymptomatic carriers of this mutation might give more insight into possible preclinical brain alterations. Using whole brain 31P MRSI at 7T, glycerophosphoethanolamine-to-phosphocreatine ratio (GPE/PCr) and uridine diphosphoglucose-to-phosphocreatine ratio (UDPG/PCr) were found to be higher in a number of brain regions in asymptomatic carriers compared with asymptomatic non-carriers. The increased GPE/PCr and UDPG/PCR might respectively indicate an increased catabolism of the cell membranes and an imbalance of energy metabolism.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords